Current
20.4×
5-Year Average
67.6×
All-Time High
399.8×
All-Time Low
10.6×
P/E Ratio daily chart for Boston Scientific (BSX)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for Boston Scientific (BSX) from 2001 to 2025
| 2025 | $141.38B | $2.89B | 48.9× | -22.1× | |
| 2024 | $131.68B | $1.85B | 71.1× | +17.9× | |
| 2023 | $84.71B | $1.59B | 53.2× | -41.6× | |
| 2022 | $66.29B | $699.00M | 94.8× | +36.6× | |
| 2021 | $60.54B | $1.04B | 58.2× | — | |
| 2020 | $51.33B | −$139.00M | — | — | |
| 2019 | $63.05B | $4.70B | 13.4× | -15.9× | |
| 2018 | $48.92B | $1.67B | 29.3× | -298.1× | |
| 2017 | $34.04B | $104.00M | 327.3× | +242.5× | |
| 2016 | $29.46B | $347.00M | 84.9× | — | |
| 2015 | $23.87B | −$239.00M | — | — | |
| 2014 | $17.58B | $267.00M | 65.8× | — | |
| 2013 | $15.98B | −$121.00M | — | — | |
| 2012 | $7.83B | −$3.96B | — | — | |
| 2011 | $7.72B | $415.00M | 18.6× | — | |
| 2010 | $11.56B | −$1.06B | — | — | |
| 2009 | $13.60B | −$731.00M | — | — | |
| 2008 | $11.62B | −$2.04B | — | — | |
| 2007 | $17.38B | −$495.00M | — | — | |
| 2006 | $25.26B | −$3.58B | — | — | |
| 2005 | $20.33B | $628.00M | 32.4× | +4.5× | |
| 2004 | $29.60B | $1.06B | 27.9× | -37.8× | |
| 2003 | $31.01B | $472.00M | 65.7× | +19.6× | |
| 2002 | $17.19B | $373.00M | 46.1× | — | |
| 2001 | $9.89B | −$54.00M | — | — |
- 202548.9×
- 202471.1×
- 202353.2×
- 202294.8×
- 202158.2×
- 2020—
- 201913.4×
- 201829.3×
- 2017327.3×
- 201684.9×
- 2015—
- 201465.8×
- 2013—
- 2012—
- 201118.6×
- 2010—
- 2009—
- 2008—
- 2007—
- 2006—
- 200532.4×
- 200427.9×
- 200365.7×
- 200246.1×
- 2001—
About P/E Ratio at Boston Scientific (BSX)
Boston Scientific (BSX) P/E ratio is 20.4× as of June 5, 2026. The 5-year average is 67.6×. The sector median currently stands at 25.0×. The current ratio is at the 0th percentile of its own 10-year history.
Boston Scientific (BSX) historical P/E ratio has ranged from a low of 10.6× (2020) to a high of 399.8× (2016) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
Boston Scientific P/E Ratio by Year
Boston Scientific P/E Ratio 2025: 48.9×
Boston Scientific (BSX) P/E ratio in 2025 was 48.9×, contracted from 71.1× the prior year.
Boston Scientific P/E Ratio 2024: 71.1×
Boston Scientific (BSX) P/E ratio in 2024 was 71.1×, expanded from 53.2× the prior year.
Boston Scientific P/E Ratio 2023: 53.2×
Boston Scientific (BSX) P/E ratio in 2023 was 53.2×, contracted from 94.8× the prior year.
Boston Scientific P/E Ratio 2022: 94.8×
Boston Scientific (BSX) P/E ratio in 2022 was 94.8×, expanded from 58.2× the prior year.
Boston Scientific P/E Ratio 2021: 58.2×
Boston Scientific (BSX) P/E ratio in 2021 was 58.2×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of Boston Scientific (BSX), ranked by P/E ratio.
| 22.2× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 12.3× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric